Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
about
Randomised clinical trial: mucosal protection combined with acid suppression in the treatment of non-erosive reflux disease - efficacy of Esoxx, a hyaluronic acid-chondroitin sulphate based bioadhesive formulation.A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
P2860
Irsogladine maleate and rabeprazole in non-erosive reflux disease: A double-blind, placebo-controlled study.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@ast
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@en
type
label
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@ast
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@en
prefLabel
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@ast
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@en
P2093
P2860
P356
P1476
Irsogladine maleate and rabepr ...... ind, placebo-controlled study.
@en
P2093
Hiroki Yuhara
Jun Nakamura
Masashi Matsushima
Muneki Igarashi
Shingo Tsuda
Takayoshi Suzuki
Tetsufumi Uchida
P2860
P304
P356
10.3748/WJG.V21.I16.5023
P407
P577
2015-04-01T00:00:00Z